BridgeMD
New treatment option for Prostate Adenocarcinoma
Official title Focal Radiation Therapy (HDR-Brachytherapy) for the Treatment of Prostate Cancer
ClinicalTrials.gov ID: NCT07468903
What this study is testing
- What it's testing
- This clinical trial tests the effect of focal radiation therapy, high dose rate-brachytherapy (HDR-BT), in treating patients with prostate cancer. Prostate cancer is the most diagnosed cancer in men and there are many treatments available, including surgery and radiation therapy.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 40 and older, men only
You may be able to join if
- Histologically confirmed diagnosis of prostate adenocarcinoma within 90 days prior to registration via systematic biopsy
- Multiparametric MRI (mp-MRI) confirmed lesion(s)
- No distant or locally advanced disease on standard staging exams as indicated
- Bone scan and abdominopelvic computed tomography (CT)/MRI OR
- PSMA PET
You likely can't join if
- Radiographic nodal or distant metastatic disease
- Lesion(s) comprising \> 40% of total prostate volume
- Prior radiotherapy to the pelvis
- Gleason score \> 6 disease outside intended gross target volume (GTV)/target region(s)
See the full eligibility criteria
- Histologically confirmed diagnosis of prostate adenocarcinoma within 90 days prior to registration via systematic biopsy
- Multiparametric MRI (mp-MRI) confirmed lesion(s)
- No distant or locally advanced disease on standard staging exams as indicated
- Bone scan and abdominopelvic computed tomography (CT)/MRI OR
- PSMA PET
- Eastern Cooperative Oncology Group (ECOG)/Zubrod performance status 0/1 within 60 days prior to enrollment
- Age ≥ 40
- Radiographic nodal or distant metastatic disease
- Lesion(s) comprising \> 40% of total prostate volume
- Prior radiotherapy to the pelvis
- Gleason score \> 6 disease outside intended gross target volume (GTV)/target region(s)
The study team makes the final eligibility decision.
Where it's taking place
- Los Angeles, California, United States
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling male, 40 years and older. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Los Angeles, California, United States. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.